{"entity":{"type":"insider","cik":"0001837648","url":"/insider/0001837648","json_url":"/insider/0001837648.json","name":"Huizinga Robert Bindert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2021-09-08","last":"2022-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Huizinga Robert Bindert","source":"filing","n_filings":5,"first_seen":"2021-09-08","last_seen":"2022-03-04"}],"transactions":[{"id":6334077,"accession":"0001628280-22-005118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-22-005118","line_url":"/filing/0001628280-22-005118#line-2","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837648","owner_name":"Huizinga Robert Bindert","owner_display_name":"Huizinga Robert Bindert","owner_url":"/insider/0001837648","role":"Officer (EVP of Research)","role_mark":"O","role_mark_label":"Officer (EVP of Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4849.0,"shares_display":"4,849","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":58236.49,"total_display":"58,236.49","total_whole":"58,236","shares_owned_after":69379.0,"shares_owned_after_display":"69,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-04","scope":"insider"},{"id":4909543,"accession":"0001628280-21-020527","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-020527","line_url":"/filing/0001628280-21-020527#line-2","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837648","owner_name":"Huizinga Robert Bindert","owner_display_name":"Huizinga Robert Bindert","owner_url":"/insider/0001837648","role":"Officer (EVP of Research)","role_mark":"O","role_mark_label":"Officer (EVP of Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130000.0,"shares_display":"130,000","price_per_share":29.75,"price_display":"29.75","price_state":"stated","total_value":3867500.0,"total_display":"3,867,500.00","total_whole":"3,867,500","shares_owned_after":65728.0,"shares_owned_after_display":"65,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-25","filed_date":"2021-10-26","scope":"insider"},{"id":5267221,"accession":"0001628280-21-019051","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-21-019051","line_url":"/filing/0001628280-21-019051","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837648","owner_name":"Huizinga Robert Bindert","owner_display_name":"Huizinga Robert Bindert","owner_url":"/insider/0001837648","role":"Officer (EVP of Research)","role_mark":"O","role_mark_label":"Officer (EVP of Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32500.0,"shares_display":"32,500","price_per_share":23.985632,"price_display":"23.99","price_state":"stated","total_value":779533.04,"total_display":"779,533.04","total_whole":"779,533","shares_owned_after":106092.0,"shares_owned_after_display":"106,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-22","scope":"insider","n_lines":2},{"id":5473151,"accession":"0001628280-21-018595","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-21-018595","line_url":"/filing/0001628280-21-018595#line-3","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837648","owner_name":"Huizinga Robert Bindert","owner_display_name":"Huizinga Robert Bindert","owner_url":"/insider/0001837648","role":"Officer (EVP of Research)","role_mark":"O","role_mark_label":"Officer (EVP of Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22500.0,"shares_display":"22,500","price_per_share":21.75,"price_display":"21.75","price_state":"stated","total_value":489375.0,"total_display":"489,375.00","total_whole":"489,375","shares_owned_after":106092.0,"shares_owned_after_display":"106,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-14","scope":"insider"},{"id":5473148,"accession":"0001628280-21-018595","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-018595","line_url":"/filing/0001628280-21-018595","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837648","owner_name":"Huizinga Robert Bindert","owner_display_name":"Huizinga Robert Bindert","owner_url":"/insider/0001837648","role":"Officer (EVP of Research)","role_mark":"O","role_mark_label":"Officer (EVP of Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.795,"price_display":"19.80","price_state":"stated","total_value":197950.0,"total_display":"197,950.00","total_whole":"197,950","shares_owned_after":133592.0,"shares_owned_after_display":"133,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-14","scope":"insider","n_lines":2},{"id":4799411,"accession":"0001628280-21-018218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-018218","line_url":"/filing/0001628280-21-018218#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837648","owner_name":"Huizinga Robert Bindert","owner_display_name":"Huizinga Robert Bindert","owner_url":"/insider/0001837648","role":"Officer (EVP of Research)","role_mark":"O","role_mark_label":"Officer (EVP of Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":18.3,"price_display":"18.30","price_state":"stated","total_value":91500.0,"total_display":"91,500.00","total_whole":"91,500","shares_owned_after":138592.0,"shares_owned_after_display":"138,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Officer (EVP of Research)","n_filings":5,"first_seen":"2021-09-08","last_seen":"2022-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001837648","retrieved_at":"2026-08-23T10:03:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}